TRULICITY

This brand name is authorized in United States. It is also authorized in Australia, Austria, Brazil, Canada, Croatia, Cyprus, Ecuador, Estonia, Finland, France, Hong Kong SAR China, Ireland, Israel, Italy, Japan, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Spain, Turkey, UK.

Active ingredients

The drug TRULICITY contains one active pharmaceutical ingredient (API):

1	Dulaglutide UNII WTT295HSY5 - DULAGLUTIDE
	Dulaglutide is a long-acting glucagon-like peptide 1 (GLP-1) receptor agonist. Dulaglutide exhibits several antihyperglycaemic actions of GLP-1. In the presence of elevated glucose concentrations, dulaglutide increases intracellular cyclic AMP (cAMP) in pancreatic beta cells leading to insulin release. Dulaglutide suppresses glucagon secretion which is known to be inappropriately elevated in patients with type 2 diabetes.
	Read more about Dulaglutide

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
TRULICITY Solution for injection	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A10BJ05		A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BJ Glucagon-like peptide-1 (GLP-1) analogues
Discover more medicines within A10BJ05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	11364D
BR	Câmara de Regulação do Mercado de Medicamentos	507615120019102, 507615120019202, 507615120019302, 507615120019402, 507615120019502, 507615120019602
CA	Health Products and Food Branch	02448599, 02448602
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	33-MBE-1115, 38-MBE-0116
EE	Ravimiamet	1670701, 1670712, 1670723, 1670734, 1670745, 1670756, 1670778, 1670789, 1670790, 1670802, 1832644, 1832655, 1832666, 1832677, 1832688, 1832699
ES	Centro de información online de medicamentos de la AEMPS	114956002, 114956007
FI	Lääkealan turvallisuus- ja kehittämiskeskus	391550, 564626
FR	Base de données publique des médicaments	62733600, 63787647
GB	Medicines & Healthcare Products Regulatory Agency	284611, 284625, 392327, 392331
HK	Department of Health Drug Office	64233, 64234
IL	מִשְׂרַד הַבְּרִיאוּת	7841, 7842
IT	Agenzia del Farmaco	043783012, 043783024, 043783036, 043783048, 043783051, 043783063, 043783075, 043783087, 043783099, 043783101, 043783113, 043783125, 043783137, 043783149, 043783152, 043783164
JP	医薬品医療機器総合機構	2499416G1029
LT	Valstybinė vaistų kontrolės tarnyba	1075116, 1075117, 1075118, 1075431, 1075432, 1075433, 1075434, 1075435, 1075436, 1075437, 1091503, 1091504, 1091505, 1091506, 1091507, 1091508
NL	Z-Index G-Standaard, PRK	124141, 124168, 206539, 206547
NZ	Medicines and Medical Devices Safety Authority	21737
PL	Rejestru Produktów Leczniczych	100332791, 100332845, 100446649, 100446655, 100446661, 100463067
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W61461001, W61462001, W61462002, W67148001, W67149001
SG	Health Sciences Authority	14967P, 14968P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699673954394, 8699673954400, 8699673954431, 8699673954448
US	FDA, National Drug Code	0002-1433, 0002-1434, 0002-2236, 0002-3182, 50090-3484